Our study also showed that the NF-κB target gene BCL2A1, an anti-apoptotic member of the BCL-2 family already known to be overexpressed in DLBCL, was up-regulated in CD79B-mutated DLBCLs [32,41,42]. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.